Ann McGee currently serves as Chief Innovation Officer and Board Chair at MIAS Pharma Limited, a role held since January 2017, where Ann is also the Founder and Managing Director/CEO. McGee's prior experience includes key positions at PharmaLex, such as Executive Vice President for Quality Management & Compliance and Managing Director of PharmaLex Ireland, as well as serving as Associate Consultant. Earlier, McGee owned McGee Pharma International, specializing in Quality Systems and regulatory compliance. McGee's career also encompasses important roles at the Pharmaceutical Society of Ireland as Registrar and Secretary, and as Senior Inspector at the Health Products Regulatory Authority. Educational qualifications include a Master of Science and a Bachelor of Science in Pharmacy, both from Trinity College Dublin. McGee has received multiple awards highlighting achievements in business and entrepreneurship.
This person is not in any teams
This person is not in any offices
MIAS Pharma Limited
MIAS Pharma Limited is a company setup to facilitate pharmaceutical companies to import human medicinal product in to the European Market. As your European partner we can provide contract services which will enable you to import and batch release product into Europe in a compliant manner. MIAS Pharma Limited holds two MIAs (Manufacturing and Importation Authorisations) to cover medicinal products for human use in EU/EEA: 1. MIA for Investigational Medicinal Products (IMPs) 2. MIA for Commercial Products MIAS Pharma can also provide oversight of: 1. European Qualified Person (QP) services 2. Regulatory compliance of manufacturing activities 3. Regulatory compliance of Analytical Testing and Retesting 4. Regulatory compliance of Repackaging / Relabelling services 5. Regulatory compliance of Shipment and Transportation activities 6. Compliance with responsibilities as a Market Authorisation Holder (MAH)